Free Republic

Experimental Data Force Researchers to Admit There’s “No Such Thing As Junk RNA” Originally, proponents of neo-Darwinian evolution lauded “junk” DNA as functionless genetic garbage that showed life is the result of blind and random mutational events. Then “junk” DNA was disproved by the discovery that the vast majority of DNA is being transcribed into RNA. Did the failure of this Darwinian assumption cause evolutionists to terminate their love affair with biological “junk”? Of course not. They just shifted their argument back, claiming that the cell is full of “junk RNA”—DNA that is being transcribed into RNA but still does...

Shuffling genetic information has long been framed as a biological mechanism that can generate variety as well as fuel evolution. However, new details of a common cellular genetic shuffling process called “crossing over” reveal a tightly controlled system that operates under strict parameters and requires highly specified cellular machinery. It is as if each generation was programmed to have variation, and that variation had strict limitations—limitations that would preclude Darwinian evolution...

Oct 20, 2009 — Every once in awhile it’s fun to look at what biochemists and biophysicists are discovering about the cell. Since you have several trillion of cells in your body, think about some of these cool cell tricks going on inside of you right now...

Weekend Roundup --snip-- Picture Highlight: the new Herschel Space Telescope, is seeing first light and creating dramatic images of gas clouds in the Milky Way...

A buildup of chemical bonds on certain cancer-promoting genes, a process known as hypermethylation, is widely known to render cells cancerous by disrupting biological brakes on runaway growth. Now, Johns Hopkins scientists say the reverse process — demethylation — which wipes off those chemical bonds may also trigger more than half of all cancers. One potential consequence of the new research is that demethylating drugs now used to treat some cancers may actually cause new cancers as a side effect. "It's much too early to say for certain, but some patients could be at risk for additional primary tumors, and...

One of the current handicaps of cancer treatments is the difficulty of aiming these treatments at destroying malignant cells without killing healthy cells in the process. But a new study by McMaster University researchers has provided insight into how scientists might develop therapies and drugs that more carefully target cancer, while sparing normal healthy cells Mick Bhatia, scientific director of the McMaster Stem Cell and Cancer Research Institute in the Michael G. DeGroote School of Medicine, and his team of investigators have demonstrated – for the first time – the difference between normal stem cells and cancer stem cells in...